PBSC mobilization

Transfusion and Apheresis Science

Volumn 31, Issue 3, 2004, Pages 233-243

  Takeyama, Kunihiko ^a   Ohto, Hitoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Cytokine; Hematopoietic stem cell; New agent; Peripheral blood stem cell (PBSC) mobilization; Poor mobilizer

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; CYTOKINE; ERYTHROPOIETIN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH HORMONE; INTERLEUKIN 3; LACTATE DEHYDROGENASE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR; URIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; BLADDER DISEASE; BLOOD TOXICITY; BONE MARROW; BONE MARROW DISEASE; BONE PAIN; CARDIOTOXICITY; CLINICAL PRACTICE; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; HEMATOLOGY; HEMATOPOIETIC STEM CELL; HEMORRHAGIC CYSTITIS; HUMAN; NEUTROPENIA; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; SIDE EFFECT; STEM CELL MOBILIZATION;

CYTOKINES; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 8844260381     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2004.09.007     Document Type: Review

References (71)

1. W.I. Bensinger, P.J. Martin, B. Storer, R. Clift, S.J. Forman, and R. Negrin Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers New Engl. J. Med. 344 2001 175 181
2. M. Korbling, and Z. Estrov Adult stem cells for tissue repair-a new therapeutic concept? New Engl. J. Med. 349 2003 570 582
3. G. Tricot, S. Jagannath, D. Vesole, J. Nelson, S. Tindle, and L. Miller Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients Blood 85 1995 588 596
4. W. Bensinger, F. Appelbaum, S. Rowley, R. Storb, J. Sanders, and K. Lilleby Factors that influence collection and engraftment of autologous peripheral-blood stem cells J. Clin. Oncol. 13 1995 2547 2555
5. C.H. Weaver, B. Hazelton, R. Birch, P. Palmer, C. Allen, and L. Schwartzberg An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy Blood 86 1995 3961 3969
6. S. Siena, R. Schiavo, P. Pedrazzoli, and C. Carlo-Stella Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy J. Clin. Oncol. 18 2000 1360 1377
7. S. Siena, M. Bregni, B. Brando, N. Belli, F. Ravagnani, and L. Gandola Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients Blood 77 1991 400 409
8. M. Keeney, I. Chin-Yee, K. Weir, J. Popma, R. Nayar, and D.R. Sutherland Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering Cytometry 34 1998 61 70
9. S. Olivero, T. Alario, P. Ladaique, M. Haccoun, P. Viens, and D. Blaise CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol Bone Marrow Transplant. 23 1999 387 394
10. K. Gutensohn, I. Carrero, W. Krueger, N. Kroeger, P. Schafer, and K. Luedemann Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products Transfusion 39 1999 1220 1226
11. U. Duhrsen, J.L. Villeval, J. Boyd, G. Kannourakis, G. Morstyn, and D. Metcalf Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients Blood 72 1988 2074 2081
12. M.A. Socinski, S.A. Cannistra, A. Elias, K.H. Antman, L. Schnipper, and J.D. Griffin Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man Lancet 1 1988 1194 1198
13. C.M. Richman, R.S. Weiner, and R.A. Yankee Increase in circulating stem cells following chemotherapy in man Blood 47 1976 1031 1039
14. T. Demirer, C.D. Buckner, B. Storer, K. Lilleby, S. Rowley, and R. Clift Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor J. Clin. Oncol. 15 1997 684 690
15. A. Kohno, K. Takeyama, M. Narabayashi, R. Okamoto, I. Adachi, and K. Tobinai Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor Bone Marrow Transplant. 15 1995 49 54
16. K. Takeyama, M. Ogura, Y. Morishima, M. Kasai, Y. Kiyama, and K. Ohnishi A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma Jpn. J. Clin. Oncol. 33 2003 78 85
17. M. Narabayashi, K. Takeyama, T. Fukutomi, Y. Tokuda, T. Tajima, and A. Okumura A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study Group Jpn. J. Clin. Oncol. 29 1999 285 290
18. W. Brugger, K. Bross, J. Frisch, P. Dern, B. Weber, and R. Mertelsmann Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin Blood 79 1992 1193 1200
19. D. Kotasek, K.M. Shepherd, R.E. Sage, B.M. Dale, J.E. Norman, and P. Charles Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors Bone Marrow Transplant. 9 1992 11 17
20. G. Koumakis, M. Vassilomanolakis, H. Hatzichristou, V. Barbounis, J. Filis, and K. Papanastasiou Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies Bone Marrow Transplant. 18 1996 1065 1072
21. E. Copelan, S. Hoshaw-Woodard, P. Elder, S. Penza, S. Farag, and G. Marcucci Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation Bone Marrow Transplant. 34 2004 85 87
22. C. Hosing, M. Munsell, S. Yazji, B. Andersson, D. Couriel, and M. de Lima Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma Ann. Oncol. 13 2002 450 459
23. J. Pedersen-Bjergaard, M.K. Andersen, and D.H. Christiansen Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation Blood 95 2000 3273 3279
24. I.N. Micallef, D.M. Lillington, J. Apostolidis, J.A. Amess, M. Neat, and J. Matthews Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies J. Clin. Oncol. 18 2000 947 955
25. P. Anderlini, D. Przepiorka, R. Champlin, and M. Korbling Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals Blood 88 1996 2819 2825
26. A.P. Grigg, A.W. Roberts, H. Raunow, S. Houghton, J.E. Layton, and A.W. Boyd Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers Blood 86 1995 4437 4445
27. W.I. Bensinger, C.H. Weaver, F.R. Appelbaum, S. Rowley, T. Demirer, and J. Sanders Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 85 1995 1655 1658
28. M. Korbling, D. Przepiorka, Y.O. Huh, H. Engel, K. van Besien, and S. Giralt Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts Blood 85 1995 1659 1665
29. N. Schmitz, P. Dreger, M. Suttorp, E.B. Rohwedder, T. Haferlach, and H. Loffler Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood 85 1995 1666 1672
30. G. Fischmeister, and H. Gadner Granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor for collection of peripheral blood progenitor cells from healthy donors Curr. Opin. Hematol. 7 2000 150 155
31. T. Demirer, M. Ayli, M. Ozcan, N. Gunel, R. Haznedar, and M. Dagli Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF Br. J. Haematol. 116 2002 468 474
32. P.J. Stiff Management strategies for the hard-to-mobilize patient Bone Marrow Transplant. 23 Suppl. 2 1999 S29 33
33. M. Andre, E. Baudoux, D. Bron, J.L. Canon, V. D'Hondt, and M.F. Fassotte Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies Transfusion 43 2003 50 57
34. C.H. Weaver, K.A. Schulman, and C.D. Buckner Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim Bone Marrow Transplant. 27 Suppl 2 2001 S23 S29
35. Y. Gazitt, N. Callander, C.O. Freytes, P. Shaughnessy, Q. Liu, and T.W. Tsai Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: a randomized prospective study J. Hematother. Stem Cell Res. 9 2000 737 748
36. A. Ballestrero, F. Ferrando, A. Garuti, P. Basta, R. Gonella, and P. Stura Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF J. Clin. Oncol. 17 1999 1296 1303
37. M.J. Watts, I. Addison, S.J. Ings, S.G. Long, S. Hartley, and S. Warrington Optimal timing for collection of PBPC after glycosylated G-CSF administration Bone Marrow Transplant. 21 1998 365 368
38. V. Lee, C.K. Li, M.M. Shing, K.W. Chik, K. Li, and K.S. Tsang Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases Bone Marrow Transplant. 25 2000 931 935
39. F.A. Holmes, J.A. O'Shaughnessy, S. Vukelja, S.E. Jones, J. Shogan, and M. Savin Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer J. Clin. Oncol. 20 2002 727 731
40. M.D. Green, H. Koelbl, J. Baselga, A. Galid, V. Guillem, and P. Gascon A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy Ann. Oncol. 14 2003 29 35
41. K. Makita, K. Ohta, A. Mugitani, K. Hagihara, T. Ohta, and T. Yamane Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest Bone Marrow Transplant. 33 2004 661 665
42. P. Anderlini, F.A. Chan, R.E. Champlin, M. Korbling, and S.S. Strom Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development Bone Marrow Transplant. 30 2002 661 663
43. C.S. Rosenfeld, B. Bolwell, A. LeFever, R. Taylor, A. List, and J. Fay Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF Bone Marrow Transplant. 17 1996 179 183
44. A. Weaver, J. Chang, E. Wrigley, E. de Wynter, P.J. Woll, and M. Lind Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer J. Clin. Oncol. 16 1998 2601 2612
45. E.J. Shpall, C.A. Wheeler, S.A. Turner, S. Yanovich, R.A. Brown, and A.L. Pecora A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients Blood 93 1999 2491 2501
46. T. Eto, Y. Takamatsu, M. Harada, N. Harada, K. Akashi, and T. Teshima Effects of macrophage colony-stimulating factor (M-CSF) on the mobilization of peripheral blood stem cells Bone Marrow Transplant. 13 1994 125 129
47. L. Pierelli, A. Perillo, S. Greggi, G. Salerno, P.B. Panici, and G. Menichella Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison J. Clin. Oncol. 17 1999 1288 1295
48. C.F. Waller, F. von Lintig, A. Daskalakis, V. Musahl, and W. Lange Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy Bone Marrow Transplant. 24 1999 19 24
49. A. Perillo, L. Pierelli, G. Scambia, R. Serafini, U. Paladini, and M.G. Salerno Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF Transfusion 41 2001 674 680
50. A. Aiuti, I.J. Webb, C. Bleul, T. Springer, and J.C. Gutierrez-Ramos The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood J. Exp. Med. 185 1997 111 120
51. D. Schols, S. Struyf, J. Van Damme, J.A. Este, G. Henson, and E. De Clercq Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4 J. Exp. Med. 186 1997 1383 1388
52. G.A. Donzella, D. Schols, S.W. Lin, J.A. Este, K.A. Nagashima, and P.J. Maddon AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor Nat. Med. 4 1998 72 77
53. C.C. Bleul, M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, and J. Sodroski The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 382 1996 829 833
54. E. Oberlin, A. Amara, F. Bachelerie, C. Bessia, J.L. Virelizier, and F. Arenzana-Seisdedos The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 Nature 382 1996 833 835
55. E. De Clercq, and D. Schols Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists Antivir. Chem. Chemother. 12 Suppl 1 2001 19 31
56. C.W. Hendrix, C. Flexner, R.T. MacFarland, C. Giandomenico, E.J. Fuchs, and E. Redpath Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers Antimicrob. Agents Chemother. 44 2000 1667 1673
57. W.C. Liles, H.E. Broxmeyer, E. Rodger, B. Wood, K. Hubel, and S. Cooper Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist Blood 102 2003 2728 2730
58. S.M. Devine, N. Flomenberg, D.H. Vesole, J. Liesveld, D. Weisdorf, and K. Badel Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma J. Clin. Oncol. 22 2004 1095 1102
59. N. Flomenberg, J. DiPersio, J. Liesveld, J. McCarty, S. Rowley, and D. Vesole AMD3100 + G-CSF Hematopoietic Progenitor Cell (HPC) Mobilization Is Safe, Effective, and Superior to Mobilization with G-CSF Alone Blood 102 2003 39a
60. C. Hannum, J. Culpepper, D. Campbell, T. McClanahan, S. Zurawski, and J.F. Bazan Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs Nature 368 1994 643 648
61. S. Hudak, B. Hunte, J. Culpepper, S. Menon, C. Hannum, and L. Thompson-Snipes FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units Blood 85 1995 2747 2755
62. Lebsack ME, McKenna HJ, Hoek J, Feng A, Maraskovsky E, Hayes FA. FLT3 ligand (MOBIST) administered in combination with GM-CSF or G-CSF to healthy volunteers. ASCO annual meeting abstract 1998; #300
63. B. Pulendran, J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, and C. Chalouni Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo J. Immunol. 165 2000 566 572
64. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
65. W.J. Murphy, G. Tsarfaty, and D.L. Longo Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine Blood 80 1992 1443 1447
66. C. Carlo-Stella, M. Di Nicola, R. Milani, P. Longoni, M. Milanesi, and C. Bifulco Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone Exp. Hematol. 32 2004 171 178
67. C. Carlo-Stella, M. Di Nicola, R. Milani, A. Guidetti, M. Magni, and M. Milanesi Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers Blood 103 2004 3287 3295
68. M. Mitterer, J. Hirber, I. Gentilini, O. Prinoth, P. Fabris, and B. Emmerich Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF Bone Marrow Transplant. 18 1996 611 617
69. F. Liu, J. Poursine-Laurent, and D.C. Link Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF Blood 95 2000 3025 3031
70. A.W. Roberts, S. Foote, W.S. Alexander, C. Scott, L. Robb, and D. Metcalf Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor Blood 89 1997 2736 2744
71. A. Kessinger, S. Mann, B.O. Murphy, J.D. Jackson, and J.G. Sharp Circulating factors may be responsible for murine strain-specific responses to mobilizing cytokines Exp. Hematol. 29 2001 775 778